[go: up one dir, main page]

WO2007026036A3 - Use of a mycosporin-type amino acid (m-gly) as an antioxidant - Google Patents

Use of a mycosporin-type amino acid (m-gly) as an antioxidant Download PDF

Info

Publication number
WO2007026036A3
WO2007026036A3 PCT/ES2006/000489 ES2006000489W WO2007026036A3 WO 2007026036 A3 WO2007026036 A3 WO 2007026036A3 ES 2006000489 W ES2006000489 W ES 2006000489W WO 2007026036 A3 WO2007026036 A3 WO 2007026036A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycosporin
amino acid
gly
antioxidant
type amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2006/000489
Other languages
Spanish (es)
French (fr)
Other versions
WO2007026036A2 (en
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Malaga
Original Assignee
Universidad de Malaga
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Malaga filed Critical Universidad de Malaga
Publication of WO2007026036A2 publication Critical patent/WO2007026036A2/en
Publication of WO2007026036A3 publication Critical patent/WO2007026036A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a mycosporin-type amino acid (M-gly) which can be used as an antioxidant and which is suitable for use in the biotechnological industry. The invention outlines the potential use of a mycosporin (MAA)-type amino acid as an antioxidant substance, specifically M-gly isolated from marine lichen Lichina pygmaea, and to the possible use thereof in pharmaceutical, nutraceutical or functional food preparations, among others, for the prevention of oxidative stress.
PCT/ES2006/000489 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (m-gly) as an antioxidant Ceased WO2007026036A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200502162 2005-08-31
ES200502162A ES2301294B1 (en) 2005-08-31 2005-08-31 USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING.

Publications (2)

Publication Number Publication Date
WO2007026036A2 WO2007026036A2 (en) 2007-03-08
WO2007026036A3 true WO2007026036A3 (en) 2007-05-10

Family

ID=37809230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000489 Ceased WO2007026036A2 (en) 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (m-gly) as an antioxidant

Country Status (2)

Country Link
ES (3) ES2301438B1 (en)
WO (1) WO2007026036A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317741B1 (en) * 2006-06-20 2010-02-10 Universidad De Malaga COMPOSITION FOR SOLAR PROTECTION BASED ON ALGAE AND LIQUEN EXTRACTS.
CN109260045A (en) * 2018-10-17 2019-01-25 拉芳家化股份有限公司 A kind of spore of bacterium containing class element-glycine from anti-corrosion moisturizing essence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904064D0 (en) * 1989-12-01 1989-12-01 Astra Ab IMPROVED METHOD OF PREPARING AND INTERMEDIATE FOR THE MANUFACTURE OF BAMBUTEROL
FR2655268B1 (en) * 1989-12-06 1994-10-14 Secma USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS.
FR2803201B1 (en) * 1999-12-30 2004-11-26 Gelyma ALGAE EXTRACT WITH FILTERING ACTIVITY WITH RESPECT TO ULTRAVIOLET RADIATION
ATE420623T1 (en) * 2001-11-14 2009-01-15 Larena MEDIUM CONTAINING A RED ALGAE EXTRACT OF THE GENUS PORPHYRA AND ITS USE TO PROTECT CELLS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DUNLAP W.Y. AND YAMAMOTO Y.: "Small-molecule antioxidants in marine organisms: antioxidant activity of mycosporine-glycine", COMP. BIOCHEM. PHYSIOL., vol. 112B, no. 1, 16 February 1995 (1995-02-16), pages 105 - 114, XP003012917 *

Also Published As

Publication number Publication date
ES2301294B1 (en) 2009-05-01
ES2301439A1 (en) 2008-06-16
ES2301438A1 (en) 2008-06-16
ES2301439B1 (en) 2009-05-01
ES2301294A1 (en) 2008-06-16
WO2007026036A2 (en) 2007-03-08
ES2301438B1 (en) 2009-05-01

Similar Documents

Publication Publication Date Title
WO2009017840A9 (en) Protein and isolated or purified amino acid product containing compositions and uses thereof
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2007079139A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
EP2341142B8 (en) HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same
WO2007059715A8 (en) Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
WO2007004878A3 (en) Infant nutrition with hydrolised proteins
WO2007137125A3 (en) A protein composition and its use in restructured meat and food products
WO2007141392A3 (en) Compositions comprising betulonic acid
ZA200806542B (en) Hla-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
EP2251018A3 (en) Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins
WO2005082927A3 (en) Antihypertensive peptides
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
IL184266A (en) 2,5 and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors and pharmaceutical compositions comprising the same
WO2007016591A3 (en) Compositions and methods for monitoring and altering protein folding and solubility
WO2008033987A3 (en) Compositions and methods to prevent cancer with cupredoxins
WO2009125409A3 (en) Fatty acid amides and uses thereof
WO2006034172A3 (en) GLYCININ-RICH AND β-CONGLYCININ-RICH VEGETABLE PROTEIN FRACTIONS
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
WO2008057300A3 (en) Trpvi antagonists and uses thereof
EP1853290A4 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
AU2003300208A1 (en) Compositions and methods for reducing the pathogen content of meat and meat products
WO2007046891A3 (en) Systems and methods for separating proteins from connective tissue
IL197887A0 (en) New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2008051448A3 (en) Methods and compositions for efficient removal of protein a from binding molecule preparations

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06807934

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06807934

Country of ref document: EP

Kind code of ref document: A2